Pages that link to "Q43235917"
Jump to navigation
Jump to search
The following pages link to Severe lactic acidosis during treatment of chronic hepatitis B with entecavir in patients with impaired liver function (Q43235917):
Displaying 50 items.
- Management of HBV and HBV/HDV-Associated Liver Cirrhosis (Q26740323) (← links)
- The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis (Q26752443) (← links)
- Chronic Hepatitis B with Spontaneous Severe Acute Exacerbation (Q26772036) (← links)
- Prophylactic managements of hepatitis B viral infection in liver transplantation (Q26772340) (← links)
- Liver transplantation for viral hepatitis in 2015 (Q26773224) (← links)
- The Role of Oxidative Stress and Antioxidants in Liver Diseases (Q26779146) (← links)
- Advanced therapeutic strategies for HBV-related acute-on-chronic liver failure (Q26800575) (← links)
- Does antiviral therapy reduce complications of cirrhosis? (Q26851410) (← links)
- The option of HBIG-free prophylaxis against recurrent HBV (Q26995972) (← links)
- Seroconversion of hepatitis B envelope antigen (HBeAg) by entecavir in a child with chronic hepatitis B (Q27023737) (← links)
- Management of chronic hepatitis B before and after liver transplantation (Q27024831) (← links)
- Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway (Q28397833) (← links)
- EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection (Q29615868) (← links)
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. (Q30391932) (← links)
- Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data (Q30829485) (← links)
- Prognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure (Q33608736) (← links)
- Chronic hepatitis B: Advances in treatment (Q33660010) (← links)
- A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B. (Q33819098) (← links)
- Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B. (Q33872988) (← links)
- HBV therapy: guidelines and open issues (Q34025181) (← links)
- Effectiveness of Hepatitis B Treatment in Clinical Practice (Q34271088) (← links)
- Review of Hepatitis B Therapeutics (Q34296410) (← links)
- Entecavir as treatment for reactivation of hepatitis B in immunosuppressed patients (Q34333145) (← links)
- Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers (Q34365421) (← links)
- Dynamic changes of lipopolysaccharide levels in different phases of acute on chronic hepatitis B liver failure (Q34490057) (← links)
- AASLD guidelines for treatment of chronic hepatitis B. (Q34501660) (← links)
- Potent antiviral therapy improves survival in acute on chronic liver failure due to hepatitis B virus reactivation (Q34552034) (← links)
- Entecavir versus Lamivudine therapy for patients with chronic hepatitis B-associated liver failure: a meta-analysis. (Q34864684) (← links)
- Safety and efficacy of entecavir for the treatment of chronic hepatitis B (Q35026611) (← links)
- Treatment of Hepatitis B in Decompensated Liver Cirrhosis (Q35207784) (← links)
- Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety (Q35535861) (← links)
- Tenofovir versus entecavir in treatment of chronic hepatitis B virus with severe acute exacerbation (Q35607794) (← links)
- Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update (Q35706189) (← links)
- Changes in Mitochondrial Toxicity in Peripheral Blood Mononuclear Cells During Four-Year Administration of Entecavir Monotherapy in Chinese Patients with Chronic Hepatitis B (Q35891653) (← links)
- Prolonged entecavir therapy is not effective for HBeAg seroconversion in treatment-naive chronic hepatitis B patients with a partial virological response (Q35960972) (← links)
- Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B. (Q36223439) (← links)
- Hepatic injury is associated with cell cycle arrest and apoptosis with alteration of cyclin A and D1 in ammonium chloride-induced hyperammonemic rats (Q36523843) (← links)
- HIV/HBV coinfection in children and antiviral therapy (Q36775147) (← links)
- Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study (Q37052093) (← links)
- De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis (Q37208157) (← links)
- Treatment of Hepatitis B: A Concise Review (Q37620340) (← links)
- Adverse effects of oral antiviral therapy in chronic hepatitis B. (Q37651892) (← links)
- Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure (Q37724704) (← links)
- Safety evaluation of telbivudine (Q37775959) (← links)
- Antiviral therapy for hepatitis B in special populations (Q37819694) (← links)
- Antiviral drugs for HBV liver disease. (Q37825909) (← links)
- Hepatitis B therapy (Q37855531) (← links)
- Treatment of special populations with chronic hepatitis B infection (Q37886158) (← links)
- Acute‐on‐chronic liver failure in chronic hepatitis B (Q37958079) (← links)
- Entecavir: a review of its use in the treatment of chronic hepatitis B in patients with decompensated liver disease (Q37964712) (← links)